Stamford, CT, February 6, 2012 – Synowledge, LLC, a market leader in pharmacovigilance, regulatory affairs, and related IT services for pharmaceutical, medical device, and biotechnology companies, is pleased to announce that it will exhibit at the 24th Annual Drug Information Association (DIA) EuroMeeting in Copenhagen, Denmark March 26-28. Synowledge will showcase its range of proven, industry-leading drug safety and regulatory affairs solutions at booth number 130.
Stamford, CT, February 6, 2012 – Synowledge, LLC, a market leader in pharmacovigilance, regulatory affairs, and related IT services for pharmaceutical, medical device, and biotechnology companies, is pleased to announce that it will exhibit at the 24th Annual Drug Information Association (DIA) EuroMeeting in Copenhagen, Denmark March 26-28. Synowledge will showcase its range of proven, industry-leading drug safety and regulatory affairs solutions at booth number 130.
The DIA is the premier global professional association for the biopharmaceutical industry, comprised of nearly 18,000 members. The EuroMeeting is the DIA’s flagship annual meeting in Europe, attracting more than 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry, contract service organizations, clinical research, regulatory agencies, health ministries, patients’ organizations and universities.
Synowledge will be exhibiting throughout the three days of the conference and attendees are invited to visit Synowledge at booth 130 to learn more about our extensive suite of drug safety and regulatory affairs solutions.
Event: 24th Annual DIA EuroMeeting
Date: March 26-28, 2012
Location: The Bella Center, Copenhagen, Denmark
Booth: 130, for floor plan, please visit:
http://www.synowledge.com/FP-Euro2012.html
For more information about the DIA 24th Annual EuroMeeting, please visit:
http://www.diahome.org/DIAHome/FlagshipMeetings/home.aspx?meetingid=25205